(Q44022811)

29 November 2017

title

Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones (English)

1 reference

29 November 2017

Andreas Mitsch

1

1 reference

29 November 2017

Markus Böhm

2

1 reference

29 November 2017

Pia Wissner

3

1 reference

29 November 2017

Isabel Sattler

4

1 reference

29 November 2017

Martin Schlitzer

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Bioorganic & Medicinal Chemistry

29 November 2017

published in

1 reference

29 November 2017

volume

10

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

2657-2662

1 reference

Protein prenylation: molecular mechanisms and functional consequences

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Ras farnesyltransferase: a new therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Farnesyltransferase as a target for anticancer drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Ras-A Molecular Switch Involved in Tumor Formation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Farnesyltransferase inhibitors: potential role in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Potent, non-thiol inhibitors of farnesyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Synthesis, molecular modeling, and structure-activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Different approaches toward an automatic structural alignment of drug molecules: applications to sterol mimics, thrombin and thermolysin inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

Amino acid substitutions that convert the protein substrate specificity of farnesyltransferase to that of geranylgeranyltransferase type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900088-3

7 January 2021

10.1016/S0968-0896(02)00088-3

Identifiers

DOI

1 reference

29 November 2017

1 reference